Lipids

Lipid based drug delivery systems

We offer a wide range of lipids and lipid derivatives to meet the needs of our customers. Additionally, we are proud to extend our product offering to include Avanti Research's extensive portfolio of high purity and specialised research grade lipids and adjuvants, furthering our commitment to bringing innovation in the hands of our customers to help them in getting groundbreaking therapies to market.

Curious about how our lipid technology can aid your drug delivery research? 

For over 30 years, Avanti Research has been working with the pharmaceutical and diagnostic industry to provide solutions that save or improve lives. We were integrally involved in the development of liposomal-based drug delivery systems and over the past decade we have concentrated on developing lipid components used in Lipid Nanoparticle (LNP) delivery technology to solve the stability and delivery issues associated with mRNA-based vaccines and therapeutics.  

Early-Stage to Commercial-Scale lipids: One seamless journey

From research innovation to GMP excellence we have the teams available to carry your innovations through to reality. Whether that is formulations support, innovative research products, custom synthesis, development of your own proprietary lipids, and more… we have you covered.  

Our lipid expertise is ever evolving to meet your needs. Our GMP capabilities now span across the globe marking our footprint in Korea, the UK, the USA, and more – ensuring your needs for global or regional scale and supply assurance.  

Discover our product brands across both synthetic and natural lipids

NatraPhos™, Avanti™, and PHAD™ are just the beginning of our product brand offerings for GMP lipids readily available. 

• NatraPhos™: A brand of natural phospholipids tailored for parenteral nutrition and small molecule applications
• Avanti™: A lipids brand that is unparalleled in purity, leveraging the expertise from our research arm and industry leaders, Avanti Research 
• PHAD™: A family of TLR4 agonists used for stimulating Th-1 type immune responses. A synthetic alternative to MPLA. 

Why choose Croda Pharma for lipids?

We continue to invest in high-purity lipids, adjuvants, and excipients—building a robust and evolving portfolio designed to meet the needs of today’s most demanding therapeutics. In a rapidly expanding lipid landscape, finding the right partner and the right products can be challenging. 

That’s why Avanti™ lipids matter more than ever. Backed by decades of expertise, global collaboration, and an unwavering commitment to quality, we’re not just participating in the market—we’re setting the standard. 

Avanti Research™ was leading the way long before the lipid boom. Partner with the teams who’ve been there since the beginning—because when it comes to lipids, we don’t just follow innovation. We’ve shaped it.